Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Multiple Sclerosis

  Free Subscription


16.04.2018

1 Brain
2 Curr Treat Options Neurol
1 J Neurol
6 J Neurol Sci
3 Mult Scler
1 PLoS One
1 Proc Natl Acad Sci U S A
2 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain

  1. CONRAD BN, Barry RL, Rogers BP, Maki S, et al
    Multiple sclerosis lesions affect intrinsic functional connectivity of the spinal cord.
    Brain. 2018 Apr 10. pii: 4965865. doi: 10.1093.
    PubMed     Text format     Abstract available


    Curr Treat Options Neurol

  2. VENASSE M, Edwards T, Pilutti LA
    Exploring Wellness Interventions in Progressive Multiple Sclerosis: an Evidence-Based Review.
    Curr Treat Options Neurol. 2018;20:13.
    PubMed     Text format     Abstract available

  3. CIOTTI JR, Cross AH
    Disease-Modifying Treatment in Progressive Multiple Sclerosis.
    Curr Treat Options Neurol. 2018;20:12.
    PubMed     Text format     Abstract available


    J Neurol

  4. TAVAZZI E, Bergsland N, Cattaneo D, Gervasoni E, et al
    Effects of motor rehabilitation on mobility and brain plasticity in multiple sclerosis: a structural and functional MRI study.
    J Neurol. 2018 Apr 7. pii: 10.1007/s00415-018-8859.
    PubMed     Text format     Abstract available


    J Neurol Sci

  5. MANCA R, Sharrack B, Paling D, Wilkinson ID, et al
    Brain connectivity and cognitive processing speed in multiple sclerosis: A systematic review.
    J Neurol Sci. 2018;388:115-127.
    PubMed     Text format     Abstract available

  6. FABIS-PEDRINI MJ, James I, Seewann A, Yau WY, et al
    Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort.
    J Neurol Sci. 2018;388:12-18.
    PubMed     Text format     Abstract available

  7. KANTOR D, Johnson K, Vieira MC, Signorovitch J, et al
    Real-world persistence with fingolimod for the treatment of multiple sclerosis: A systematic review and meta-analysis.
    J Neurol Sci. 2018;388:168-174.
    PubMed     Text format     Abstract available

  8. ZIVADINOV R, Bergsland N, Hagemeier J, Carl E, et al
    Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
    J Neurol Sci. 2018;388:175-181.
    PubMed     Text format     Abstract available

  9. GROMISCH ES, Portnoy JG, Foley FW
    Comparison of the abbreviated minimal assessment of cognitive function in multiple sclerosis (aMACFIMS) and the brief international cognitive assessment for multiple sclerosis (BICAMS).
    J Neurol Sci. 2018;388:70-75.
    PubMed     Text format     Abstract available

  10. KADRNOZKOVA L, Vaneckova M, Sobisek L, Benova B, et al
    Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year employment status in multiple sclerosis patients.
    J Neurol Sci. 2018;388:87-93.
    PubMed     Text format     Abstract available


    Mult Scler

  11. KREMER D, Kury P, Hartung HP
    ECTRIMS/ACTRIMS 2017: Closing in on neurorepair in progressive multiple sclerosis.
    Mult Scler. 2018 Apr 1:1352458518768770. doi: 10.1177/1352458518768770.
    PubMed     Text format     Abstract available

  12. MCNICHOLAS N, Lockhart A, Yap SM, O'Connell K, et al
    New versus old: Implications of evolving diagnostic criteria for relapsing-remitting multiple sclerosis.
    Mult Scler. 2018 Apr 1:1352458518770088. doi: 10.1177/1352458518770088.
    PubMed     Text format     Abstract available

  13. ALMEIDA KJ, Barreto-Soares RV, Campos-Sousa RN, Campos-Sousa MG, et al
    Pulmonary paracoccidioidomycosis associated with the use of natalizumab in multiple sclerosis.
    Mult Scler. 2018 Apr 1:1352458518763091. doi: 10.1177/1352458518763091.
    PubMed     Text format     Abstract available


    PLoS One

  14. KOZIARSKA D, Krol J, Nocon D, Kubaszewski P, et al
    Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland.
    PLoS One. 2018;13:e0194117.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  15. ZEITELHOFER M, Adzemovic MZ, Gomez-Cabrero D, Bergman P, et al
    Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis .
    Proc Natl Acad Sci U S A. 2017 Feb 14. pii: 201615783.
    PubMed     Text format     Abstract available


    Rev Neurol

  16. PEREZ-MIRALLES FC
    Daclizumab in multiple sclerosis.
    Rev Neurol. 2018;66:271-282.
    PubMed     Text format     Abstract available

  17. RIO J
    [New drugs for the treatment of multiple sclerosis].
    Rev Neurol. 2018;66:253.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: